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Abstract
Background:  Exposure to persistent organic pollutants, including polychlorinated biphenyls (PCBs) and
organochlorine pesticides, is widespread among the general population. There is evidence of adverse effects on
reproduction and early pregnancy in relation to organochlorine exposure but human studies remain limited. The
increased use of assisted reproductive technologies (ART) presents unique opportunities for the assessment of
environmental influences on early pregnancy outcomes not otherwise observable in humans, but studies need to
be designed to maximize the efficiency of the exposure data collected while minimizing exposure measurement
error.
Methods:  The present study was conducted to assess the correlation between concentrations of
organochlorines in serum and follicular fluid samples collected from a subset of women undergoing ART in a large
study that took place between 1994 and 2003, as well as the temporal reliability of serum organochlorine
concentrations among women undergoing multiple ART cycles in the study. PCB congeners (118, 138, 153, and
180), 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (p,p'-DDT), the DDT metabolite p,p'-DDE,
hexachlorobenzene (HCB), oxychlordane, trans-nonachlor and mirex were measured in 72 follicular fluid samples
and 265 serum samples collected from 110 women.
Results: Organochlorine concentrations in paired serum and follicular fluid samples were correlated, with
Pearson and Spearman coefficients ranging from 0.60 to 0.92. Serum organochlorine concentrations were two-
to three-fold greater than in follicular fluid, and a significant inverse trend was observed in the distribution of
follicular fluid:serum ratios with increasing molecular weight of the compound (p-value for trend < 0.0001). Serum
organochlorine concentrations were highly reliable over the course of several months, with intraclass correlation
coefficients ranging from 0.86 to 0.98. Finally, there was evidence for a declining trend in organochlorine
concentrations between samples collected between years 1994–1998 and those collected in 1999–2003.
Conclusion: Our results support the use of a single serum sample to adequately represent a more biologically
relevant dose (concentrations in follicular fluid), as well as exposure levels over time, in epidemiological studies
of ART outcomes in relation to organochlorine exposure.
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Background
There is concern for the potential adverse effects of envi-
ronmental exposures to persistent organic chlorinated
pollutants on fertility and pregnancy. Polychlorinated
biphenyls (PCB) are a class of synthetic, persistent,
lipophilic, chlorinated aromatic compounds that were
widely used for decades in both industrial and consumer
products. In the U.S., their production was banned in the
late 1970's. However, as a result of their extensive use and
persistence, PCBs remain ubiquitous environmental con-
taminants. The general population is exposed primarily
through ingestion of contaminated foods (e.g., fish, meat,
and dairy products), as PCBs bioaccumulate up the food
chain. Like PCBs, the organochlorine pesticides such as
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT),
hexachlorobenzene (HCB), mirex, chlordane, and others
are no longer used in the US and other industrialized
nations, but exposures still occur through various routes
and pathways due to their persistence in the environment.
PCBs, organochlorine pesticides and their metabolites
have long biological half-lives, and can be measured in
the body months or years after an exposure has occurred
[1]. Because of their persistence and ubiquity, measurable
levels of serum PCBs and organochlorine pesticides or
their metabolites are found in a high proportion of the
general population [2]. Exposure to persistent organo-
chlorines can result in an internal dose to the female
reproductive tract, as these compounds have been meas-
ured in human follicular fluid [3,4], ovarian tissue [5],
placenta, uterine muscle and amniotic fluid [6], as well as
in embryos and fetuses [7,8], providing evidence of expo-
sure to critical tissues during important windows of early
development.
Organochlorine compounds have been associated with
altered endocrine function, reduced fertility, and early
pregnancy loss in experimental animals [9,10] and lim-
ited human studies [11-13], but more research is needed
to understand potential risks associated with human
exposure. An important limiting factor in assessing risk
based on human studies is the degree of measurement
error associated with the exposure estimate(s) used in a
particular study. Two potential sources of exposure error
in epidemiological studies, among others, include: 1) the
ability of an exposure measure to predict an individual's
biologically relevant dose to an agent (i.e. validity); and 2)
the degree of temporal variability in exposure within and
between individuals (i.e. reliability). If an exposure index
is a poor surrogate for dose at the target organ of interest,
and/or if there is large intra-individual variability in expo-
sure over time compared to inter-individual variability, it
will make it more difficult to detect an association
between the exposure and outcome of interest through
the dilution of effect estimates and loss of study power
[14].
The present study was performed to determine how well
blood levels of PCBs and organochlorine pesticides reflect
levels at the target organ of interest, the ovary, and to
quantify within-person variability in serum organochlo-
rine concentrations over time. These results will be used to
guide the design and analysis in our large ongoing epide-
miological study on PCBs and organochlorine pesticide
exposure and early pregnancy loss among women under-




Details of the main study within which the present sub-
study was performed has been previously described
[15,16]. Briefly, between August 1994 and June 2003,
couples undergoing IVF or intracytoplasmic sperm injec-
tion (ICSI) were recruited through three Boston area clin-
ics to participate in a study of predictors of IVF outcome.
The main study was conducted in two phases (1994 –
1998 and 1999 – 2003) corresponding with a five-year
renewal of the study following the completion of the first
five years. Study protocols were approved by the Human
Research Committees at Brigham and Women's Hospital,
Harvard School of Public Health, and the University of
Michigan. Approximately 65% of couples who were
approached agreed to participate in the study. Couples
who required either donor oocytes or donor semen were
excluded, as were couples who were gestational carriers
and those who underwent gamete intra-fallopian transfer.
Following these exclusions, 2,350 couples were enrolled
in the main study. Many couples underwent multiple IVF/
ICSI cycles (up to six), with the average being two cycles
per couple.
Collection of serum samples
Serum samples were collected from women in the study at
"baseline" and at each IVF/ICSI cycle. Baseline samples
were collected between days one and five of a menstrual
cycle prior to the initiation of IVF/ICSI treatment. A serum
sample was also collected at each cycle during the follicu-
lar phase immediately prior to human chorionic gonado-
tropin (HCG) administration. The serum fraction was
separated for all blood samples by centrifugation for five
minutes, aliquoted, and stored at -80C until analysis.
Follicular fluid collection
Oocyte retrieval was performed approximately 36 hours
after HCG treatment. The follicular fluid was obtained
from the largest follicle (> 18 mm) visualized on ultra-
sound before using any flushing medium and only con-
sisted of fluid from one follicle. This follicle was aspirated
with the first puncture of the oocyte retrieval. The follicu-
lar fluid was transferred to a sterile Petri dish, and after the
oocyte was removed, the fluid was placed into a 15 mLEnvironmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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conical tube and centrifuged for 15 minutes. Within 30
minutes of collection, the supernatant was placed into a
clean storage tube, aliquoted, and stored at -80C.
Measurement of organochlorines in serum and follicular 
fluid
For the present exposure sub-study, serum samples from
baseline and all repeated IVF/ICSI cycles among 110
women (a total of 265 serum samples) were analyzed for
organochlorine concentrations. Women were selected
randomly within strata based on age, year of enrollment,
and IVF outcome as the first stage in a nested case-control
analysis of organochlorines and early pregnancy loss.
First-cycle follicular fluid samples were also analyzed for
62 of these women. An additional 10 follicular fluid sam-
ples from women not selected as part of the 110 above
were also analyzed for organochlorines. These samples
were included in the presentation of the population distri-
bution of follicular fluid organochorine concentrations.
Baseline serum samples were available for 85 (77%) of
the women. The primary reason for missing baseline sam-
ples related to logistical challenges in collecting a sample
from each woman in the study between days one and five
of a menstrual cycle prior to treatment.
Measurement of organochlorines in serum and follicular
fluid was conducted by the Organic Chemistry Analytical
Laboratory, Harvard School of Public Health, and the
method for serum has been described previously [17,18].
In brief, after liquid-liquid extraction and column chro-
matography clean-up the samples were analyzed by gas
chromatography with dual Micro-ECD, on two capillary
columns of different polarity using two internal stand-
ards. All final results were reported after subtracting the
amount of the analyte measured in the procedural blank
associated with the analytic batch. Samples were accom-
panied by the following quality control samples: a proce-
dural blank, matrix spike samples, and a laboratory
control sample. Each sample was spiked with two surro-
gate compounds to monitor the efficiency of the extrac-
tion procedure. Target analytes included 57 individual
PCB congeners, p,p'-DDE, p,p'-DDT, HCB, oxychlordane,
trans-nonachlor and Mirex. Since persistent organochlo-
rines partition according to the lipid content of tissues,
and serum lipid levels vary between fasting and non-fast-
ing states, a correction for serum lipids is needed for the
valid interpretation of serum levels [19]. Thus, levels were
also reported after standardizing for serum lipids as units
of ng/g total lipids to allow for comparison with other
studies. Serum total cholesterol and triglycerides were
measured enzymatically, and total lipids were calculated
by Phillips formula [19,20]. However, lipids were only
measured in 173 serum samples due to sample volume
limitations.
The method for follicular fluid was similar to serum, and
it was validated on anonymously collected follicular fluid
samples prior to analyzing the study samples. Eight 5 g
aliquots of pooled follicular fluid were fortified with
0.0144 ng of each target analyte per gram of fluid, and
three aliquots were fortified with 0.0384 ng/g of follicular
fluid. Percent recoveries for all target analytes, except oxy-
chlordane, ranged from 80% to 104%. The mean (SD)
recovery of oxychlordane was 40% (5.7%) because it was
not completely eluted from the chromatography clean-up
column since a non-polar solvent was used for all target
analytes. Values were not recovery adjusted prior to
reporting or statistical analysis.
Method detection limits (MDL) were determined as rec-
ommended by the US Environmental Protection Agency
[21]. In serum the MDL values for all target analytes were
< 0.05 ng/g, with most of the analytes < 0.01 ng/g. The
MDL for p,p'-DDE was higher because unfortified serum
had high p,p'-DDE concentrations at 6.3 ng/g. In follicular
fluid the MDLs for all target analytes were < 0.005 ng/g
with most of the analytes < 0.001 ng/g. The MDL for p,p'-
DDE was higher because unfortified follicular fluid had
high p,p'-DDE concentrations at 0.221 ng/g. Only results
involving analytes with detectable concentrations in
100% of samples are presented to avoid issues of censor-
ship or bias when including samples below the MDL.
Statistical analysis
Data analysis was conducted using SAS software (version
9.1; SAS Institute Inc., Cary, NC). Distributions of organ-
ochlorine concentrations in follicular fluid and serum
were tabulated and compared. Spearman rank correla-
tions between analytes were then calculated within each
matrix (follicular fluid and serum), as were Pearson corre-
lation coefficients following the transformation of organ-
ochlorine concentrations by the natural logarithm (ln).
Spearman and Pearson correlations were also calculated
to assess the level of agreement between paired first-cycle
follicular fluid and serum organochlorine concentrations.
The ratio of organochlorine concentrations in follicular
fluid to serum was calculated for all women and for each
analyte. Ratio distributions were tabulated, and differ-
ences between analytes compared using linear regression
with the various analytes ranked and assigned indicator
variables based on chemical properties (i.e. molecular
weight or number of chlorine atoms).
To assess between- and within-person variability in serum
organochlorine concentrations, intraclass correlation
coefficients (ICC) and their 95% confidence intervals
were calculated for both wet-weight and lipid-standard-
ized ln-adjusted concentrations of each analyte using SAS
PROC MIXED [22]. ICC is a measure of the reliability of
repeated measures over time, defined as the ratio ofEnvironmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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between-subject variance to total variance. ICC ranges
from zero to one, with values near zero indicating poor
reliability and values near one indicating high reliability
[23]. Finally, to assess temporal patterns in organochlo-
rine concentrations among women in our study, we com-
pared serum organochlorine concentrations between the
first and second phases of the main study using a student's
t-test. We also fit a mixed effects model for each analyte,
where we calculated the fixed effect for IVF/ICSI cycle
number, while accounting for random subject effects, to
assess changes in serum organochlorine concentrations
within individuals over time. This analysis was conducted
using both wet-weight and lipid-standardized concentra-
tions, as well as when using wet-weight concentrations
and including lipids as a covariate.
Results
The mean (SD) age among the women was 36 (4.0) years,
and ranged from 25 to 44 years. Among the 265 serum
samples, 14 women contributed a single sample, 57
women contributed two samples, 25 women contributed
three samples, eight women contributed four samples,
five women contributed five samples, and one woman
contributed six samples. The calendar time between the
collection of the first and the final serum sample ranged
from two to 24 months, with a median of five months.
The distribution of organochlorine concentrations in first
cycle serum and follicular fluid samples are presented in
Table 1. In both serum and follicular fluid, p,p'-DDE and
PCB 153 had the highest concentrations among the pesti-
cides and PCB congeners, respectively. Correlation coeffi-
cients between compounds in both serum and follicular
fluid are presented in Table 2. Organochlorine pesticides
(i.e., p,p'-DDE, p,p'-DDT, HCB, oxychlordane, trans-non-
achlor and mirex) were moderately correlated with each
other and with PCB congeners (correlation coefficients [r]
ranged from 0.3 and 0.7) with a couple of exceptions; in
follicular fluid trans-nonachlor was strongly correlated
with oxychlordane and with individual PCB congeners (r
≥ 0.7), and in both matrices weak correlations were found
for mirex with HCB and p,p'-DDE (r ≤ 0.2). As expected,
concentrations of PCB congeners were strongly correlated
with one another in both serum and follicular fluid (r
between 0.7 and 0.9).
Plots comparing organochlorine concentrations in first
cycle follicular fluid and serum are presented in Figure 1.
All correlation coefficients were significantly greater than
zero (p < 0.05). With the exception of the sum of PCBs, at
least one of the two correlation coefficients presented (the
Pearson or Spearman) would be classified as strong (≥
0.7) for all analytes. Correlation coefficients for the sum
of PCBs were just below 0.7, while the strongest correla-
tion (Spearman r > 0.9) was for p,p'-DDE.
The organochlorine concentrations in follicular fluid were
consistently lower than levels in serum. The distributions
of the ratios of follicular fluid to serum organochlorine
concentrations are presented in Table 3. Despite the
strong correlations between follicular fluid and serum
organochlorine concentrations, there was considerable
between-person variability in these ratios for most of the
analytes. For instance, ratios for PCB 118 ranged from
0.06 to 1.38. Follicular fluid:serum ratios were not associ-
ated with age or BMI (data not shown). One woman had
high ratios that would be considered an outlier (> 3 SD
from the mean) for several analytes, with one ratio (PCB
118) exceeding 1.0 and a number of other ratios just
below 1.0. There was also a significant inverse trend
between mean follicular fluid:serum ratio and molecular
weight in a linear regression model that used an indicator
variable to rank analytes according to molecular weight (p
< 0.0001). That is, as molecular weight increased, the fol-
licular fluid:serum ratio decreased. For example, the
median (25th, 75th) ratio value for the compound with the
lowest molecular weight (HCB, MW = 285) was 0.37
(0.29, 0.49) compared to 0.22 (0.17, 0.30) for the com-
pound with the highest molecular weight (mirex, MW =
546). A statistically significant inverse trend was also
found when assigning an indicator variable to rank ana-
lytes according to the number of chlorine atoms, though
it was not as strong as the trend observed for molecular
weight (data not shown).
The ICC values presented in Table 4, all of which are near
1.0, demonstrate the high level of reliability for serum
organochlorine concentrations over time. ICC values
ranged from 0.85 for oxychlordane to 0.98 for p,p'-DDE.
Finally, Table 5 provides evidence for a decline in organo-
chlorine levels among women in the study over time, as
concentrations in first cycle follicular fluid and serum
were consistently higher among women in the first phase
of the study (1994–1998) compared to the second phase
(1999–2003). In linear mixed effects models, cycle was
inversely associated with wet weight serum concentra-
tions of mirex and PCB congeners 138, 153 and 180.
There were suggestive inverse associations between cycle
number and p,p'-DDE and p,p'-DDT (p-values = 0.07 and
0.06, respectively). However, these associations were no
longer statistically significant when concentrations were
lipid-standardized (n = 173, results not shown).
Discussion
In the present study, we found a strong correlation
between the concentrations of organochlorine pesticides
and PCBs measured in paired serum and follicular fluid
samples, and a high degree of reliability in serum organo-
chlorine concentrations within an individual over time
periods of less than two years. Thus, measuring organo-
chlorine concentrations in a single serum sample likelyEnvironmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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reflects concentrations in follicular fluid over the course of
repeated IVF/ICSI cycles. The reliability of serum organo-
chlorine levels has been assessed throughout different
stages of pregnancy and early development [24-28]. How-
ever, to our knowledge this is the first study to assess reli-
ability of serum organochlorine concentrations over time
among women attempting to become pregnant.
In studies of patients undergoing assisted reproduction
technologies, organochlorine levels measured in follicular
fluid are likely to be a biologically relevant marker of
exposure since it reflects the ovarian microenvironment
and thus organochlorine exposure of the maturing oocyte.
During IVF treatment, women undergo superovulation to
maximize the number of oocytes that can be retrieved.
Table 1: Distribution of organochlorine pesticide and PCB concentrations (ng/g wet weight) in all first cycle serum (n = 110) and 
follicular fluid (n = 72) samples
Geometric Mean Selected Percentiles
10th 25th 50th 75th 90th 95th Max.
HCB
Serum 0.093 0.051 0.069 0.090 0.114 0.151 0.195 2.31
FF 0.032 0.017 0.025 0.035 0.044 0.057 0.072 0.588
Oxychlordane
Serum 0.045 0.024 0.033 0.046 0.062 0.088 0.094 0.156
FF 0.011 0.006 0.008 0.012 0.014 0.018 0.023 0.036
Trans-nonachlor
Serum 0.090 0.045 0.068 0.092 0.128 0.168 0.205 0.485
FF 0.018 0.008 0.013 0.020 0.027 0.031 0.040 0.138
Mirex
Serum 0.014 0.006 0.010 0.014 0.022 0.031 0.051 0.100
FF 0.004 0.001 0.002 0.004 0.006 0.008 0.009 0.040
p,p'-DDE
Serum 1.23 0.430 0.700 1.08 1.81 3.93 8.75 24.2
FF 0.384 0.123 0.223 0.363 0.878 1.85 4.26 6.74
p,p'-DDT
Serum 0.065 0.030 0.040 0.063 0.086 0.119 0.346 1.98
FF 0.013 0.005 0.009 0.014 0.019 0.028 0.047 0.116
PCB 118
Serum 0.091 0.041 0.056 0.088 0.145 0.205 0.320 0.540
FF 0.028 0.010 0.017 0.032 0.047 0.073 0.096 0.132
PCB 138
Serum 0.149 0.073 0.103 0.153 0.206 0.295 0.313 1.11
FF 0.043 0.019 0.034 0.047 0.071 0.100 0.139 0.380
PCB 153
Serum 0.257 0.119 0.181 0.260 0.358 0.521 0.591 2.33
FF 0.064 0.024 0.047 0.072 0.110 0.148 0.211 0.778
PCB 180
Serum 0.159 0.073 0.119 0.168 0.229 0.293 0.350 1.98
FF 0.039 0.013 0.021 0.045 0.060 0.100 0.111 0.640
ΣPCB
Serum 1.41 0.754 1.06 1.40 1.84 2.49 3.01 10.3
FF 0.350 0.127 0.252 0.384 0.534 0.709 0.970 3.23Environmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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During the pre-antral phase, follicular fluid, a thecal
blood filtrate, accumulates and suspends the oocyte and
the cumulus cells surrounding it. Just prior to ovulation,
when the majority of a follicle's volume consists of follic-
ular fluid, the basement membrane becomes increasingly
permeable and eventually breaks down [29]. When the
follicles are collected the follicular fluid is aspirated and
usually discarded. However, in addition to studies among
patients undergoing IVF/ICSI allowing for the assessment
of early pregnancy outcomes not observable in women
conceiving naturally (e.g. implantation, embryo quality,
etc.), another innovative aspect is the ability to collect and
analyze the follicular fluid for environmental contami-
nants as a biologically relevant exposure biomarker. How-
ever, serum may remain a more desirable matrix in
epidemiological studies since: 1) the analytical methods
for the measurement of organochlorines in serum are
well-developed; 2) organochlorine concentrations tend to
be higher in serum which would increase sample detec-
tion rates in research studies; 3) many follicle aspiration
protocols involve the use of a flushing medium (though
one was not used in the present study) which would intro-
duce error in follicular fluid organochlorine concentra-
tions; and 4) most studies to date have measured
organochlorine concentrations in serum, which facilitates
straight-forward comparisons of exposure between stud-
ies in human risk assessments – especially in the case of
reproductive health studies among the general population
in which the collection of follicular fluid is not possible.
Several previous studies have measured organochlorine
concentrations in follicular fluid [3,4,30-34]. However,
most studies were small in size and only two of the studies
reported on the association between organochlorine con-
centrations in follicular fluid and serum. The first, a Bel-
gian study among 8 women, reported strong correlations
(>0.7) between follicular fluid and serum concentrations
of PCBs 138, 153 and 180, but not PCB 118. The second
study, which was conducted among 74 women from three
regions of Canada, reported moderate to weak correla-
tions for DDE (r = 0.53), oxychlordane (r = 0.23), HCB (r
= 0.32), and sum of PCBs (r = 0.37) [30]. Reasons for the
discrepancies in the level of agreement between matrices
in the Canadian study and the present study are unclear,
but may be due to differences in exposure levels among
the two populations, differences in IVF treatment proto-
cols and follicular fluid collection, or perhaps differences
in analytical sensitivity since there was a high percentage
(over 50% for some analytes) of non-detect samples in the
Canadian study. A couple of the remaining studies stated
that there were strong correlations between serum and fol-
licular fluid organochlorine concentrations but did not
present any quantitative measures [3,31].
The present study is the first to conduct an in-depth assess-
ment of follicular fluid to serum organochlorine ratios.
Baukloh et al. [33] reported higher PCB concentrations,
but lower HCB concentrations, in follicular fluid com-
pared to matched serum samples from 12 Austrian
women. Conversely, in findings that were consistent with
the present study, Pauwels et al. [34] reported serum PCB
concentrations were on average approximately 3-fold
higher in serum compared to follicular fluid in a study of
eight Belgian women. The authors attributed this differ-
ence to the difference in lipid content between the two
matrices – follicular fluid has been reported to be approx-
imately 0.03% lipids [4] as compared to serum, which
averaged nearly 0.6% lipids among women in the present
study. Likewise, a Canadian study among 21 women
reported serum concentrations of DDE and PCBs were
approximately 2-fold higher than follicular fluid concen-
trations [3]. In the present study, we found that follicular
fluid to serum organochlorine ratios were inversely asso-
ciated with molecular weight, where HCB, which has the
lowest molecular weight among the organochlorines
measured, had the highest follicular fluid:serum ratios.
Table 2: Spearman correlation coefficients between organochlorine concentrations (ng/g) in follicular fluid (n = 72) and serum 
(n = 110)
HCB Oxy-chlordane Trans-nonachlor Mirex p,p-DDE p,p-DDT PCB 118 PCB 138 PCB 153 PCB 180 ΣPCB
HCB 0.47 0.44 0.13 0.50 0.56 0.43 0.41 0.41 0.35 0.43
Oxychlordane 0.50 0.87 0.54 0.33 0.53 0.70 0.66 0.71 0.68 0.73
Trans-nonachlor 0.42 0.88 0.61 0.43 0.54 0.76 0.69 0.75 0.70 0.77
Mirex 0.09 0.46 0.51 0.24 0.50 0.41 0.51 0.60 0.63 0.59
p,p'-DDE 0.60 0.42 0.43 0.11 0.69 0.43 0.59 0.56 0.41 0.52
p,p'-DDT 0.60 0.57 0.63 0.32 0.72 0.52 0.61 0.64 0.58 0.64
PCB 118 0.38 0.59 0.62 0.33 0.35 0.56 0.78 0.80 0.68 0.86
PCB 138 0.52 0.62 0.62 0.37 0.55 0.65 0.79 0.95 0.81 0.93
PCB 153 0.52 0.61 0.62 0.41 0.47 0.63 0.79 0.94 0.92 0.97
PCB 180 0.43 0.58 0.60 0.45 0.33 0.56 0.70 0.80 0.93 0.90
ΣPCB 0.48 0.63 0.62 0.42 0.40 0.60 0.82 0.89 0.95 0.91
*Correlation coefficients above diagonal are for follicular fluid, below diagonal are for serum.Environmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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This finding may be a result of the relative permeability of
the basement membrane to the various organochlorine
compounds, where lower molecular weight compounds
may pass through to the follicle more easily as has been
reported for serum proteins [35-37]. However, more
research is needed to explain this trend for organochlo-
rines and other environmental conditions. In addition,
more information is needed on predictors of between-
individual variability in follicular fluid:serum ratios, as
higher ratios may represent individuals with increased
susceptibility to organochlorine exposures in relation to
fertility and early pregnancy since a greater proportion of
a given exposure level may reach the target organ in those
individuals. Alternatively, inter-individual differences
may reflect variability due to treatment if they were some-
how associated with the movement of chemicals into the
follicle. For example, the influence of differing IVF treat-
ment protocols, variable estrogen environments, and fol-
licle size [38] on follicular fluid organochlorine
concentrations and follicular fluid:serum ratios should be
explored. Finally, data is also needed to determine
whether ratios are variable over time within individuals.
Our finding of lower organochlorine concentrations in
phase 2 of the study (1999–2003) compared to phase 1
(1994–1998) is consistent with other reports of temporal
Scatterplots of organochlorine concentrations measured in first-cycle serum and follicular fluid (n = 62) Figure 1
Scatterplots of organochlorine concentrations measured in first-cycle serum and follicular fluid (n = 62). Spear-
man correlation coefficients between media were as follows (all p-values < 0.05): HCB, 0.66; oxychlordane, 0.66; transnonach-
lor, 0.65; p,p'-DDE, 0.92; p,p'-DDT, 0.74; mirex, 0.80; PCB 118, 0.82; PCB 138, 0.74; PCB 153, 0.73; PCB 180, 0.73; Sum PCB, 
0.68.Environmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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declines in exposure [39-42]. The distribution of serum
organochlorine concentrations in the present study were
similar to those presented among a subset of NHANES
participants surveyed in 2001–2001 from the Third
National Report on Human Exposure [2]. Among analytes
detected in at least 50% of samples in the Third Report,
geometric mean concentrations from first cycle serum
samples in the present study were slightly higher com-
pared to the female strata in the Third Report for PCB 153
(0.28 ng/g serum versus 0.16 ng/g) and PCB 180 (0.17 ng/
g versus 0.11 ng/g), whereas p,p'-DDE concentrations
were somewhat lower in the present study (1.44 ng/g
compared to the 1.85 ng/g in the Third Report). Geomet-
ric mean serum concentrations of PCB 138, oxychlordane,
and trans-nonachlor were also slightly lower in the
present study.
Conclusion
In conclusion, although the present study found evidence
for declining organochlorine concentrations over time
and between-individual and between-analyte variability
in the ratio of follicular fluid to serum organochlorine
concentrations, our results suggest that a single serum
value indicates an individual's relative rank for biologi-
cally relevant dose in the ovary, as well as exposure level
over time, in studies of ART outcomes in relation to orga-
nochlorine exposure.
Table 3: Distribution of follicular fluid:serum ratios with analytes listed in ascending order by molecular weight (N = 62)
Molecular weight Mean Selected Percentiles
Min. 10th 25th 50th 75th 90th 95th Max.
HCB 285 0.39 0.13 0.22 0.29 0.37 0.49 0.55 0.60 0.69
p,p'-DDE 318 0.32 0.03 0.18 0.24 0.32 0.41 0.46 0.49 0.55
PCB 118 326 0.32 0.06 0.18 0.22 0.30 0.39 0.46 0.48 1.38*
p,p'-DDT 355 0.22 0.02 0.11 0.14 0.22 0.27 0.32 0.36 0.47
PCB 138 361 0.31 0.04 0.17 0.24 0.30 0.37 0.43 0.51 0.99*
PCB 153 361 0.27 0.03 0.14 0.20 0.25 0.34 0.39 0.41 0.79*
PCB 180 395 0.25 0.02 0.12 0.18 0.25 0.31 0.40 0.41 0.94*
Oxychlordane 426 0.24 0.06 0.12 0.17 0.24 0.29 0.35 0.37 0.52
Trans-nonachlor 444 0.21 0.05 0.10 0.16 0.20 0.25 0.29 0.32 0.71*
Mirex 546 0.24 0.06 0.11 0.17 0.22 0.30 0.39 0.42 0.54
ΣPCB 0.27 0.06 0.14 0.19 0.26 0.33 0.38 0.42 0.97*
*One woman was consistently an outlier for high ff:serum ratio for PCBs and trans-nonachlor. This woman also had the highest ratio for 
oxychlordane.
Table 4: Intraclass correlation coefficients (95% confidence intervals) for organochlorine concentrations (ng/g) in serum
Wet-weight concentrations Lipid-standardized
All samples; n = 266 Excluding baseline; n = 178 All samples; n = 173 Excluding baseline; n = 105
HCB 0.95 (0.93, 0.96) 0.97 (0.95, 0.98) 0.95 (0.92, 0.97) 0.97 (0.95, 0.98)
Oxychlordane 0.85 (0.80, 0.90) 0.91 (0.86, 0.94) 0.90 (0.85, 0.93) 0.93 (0.88, 0.96)
Transnonachlor 0.88 (0.83, 0.91) 0.94 (0.92, 0.96) 0.95 (0.92, 0.97) 0.94 (0.90, 0.97)
Mirex 0.88 (0.83, 0.91) 0.95 (0.93, 0.97) 0.90 (0.85, 0.93) 0.95 (0.92, 0.97)
p,p'-DDE 0.98 (0.97, 0.99) 0.98 (0.97, 0.99) 0.98 (0.97, 0.99) 0.98 (0.97, 0.99)
p,p'-DDT 0.93 (0.91, 0.95) 0.96 (0.95, 0.98) 0.95 (0.92, 0.97) 0.96 (0.92, 0.98)
PCB 118 0.92 (0.89, 0.94) 0.97 (0.96, 0.98) 0.97 (0.95, 0.98) 0.97 (0.95, 0.99)
PCB 138 0.91 (0.87, 0.93) 0.96 (0.94, 0.97) 0.96 (0.94, 0.98) 0.97 (0.95, 0.98)
PCB 153 0.91 (0.88, 0.94) 0.96 (0.93, 0.97) 0.97 (0.95, 0.98) 0.97 (0.94, 0.98)
PCB 180 0.91 (0.87, 0.93) 0.95 (0.93, 0.97) 0.96 (0.94, 0.97) 0.97 (0.95, 0.98)
Sum PCB 0.83 (0.77, 0.88) 0.92 (0.89, 0.95) 0.88 (0.83, 0.92) 0.93 (0.88, 0.96)
Cholesterolb 0.58 (0.43, 0.71) 0.67 (0.49, 0.82)
Triglyceridesb 0.85 (0.78, 0.90) 0.86 (0.77, 0.92)
Total lipidsb 0.78 (0.69, 0.86) 0.83 (0.71, 0.90)
n = 265 serum samples from 110 women.
avalues transformed by the natural logarithm.
bcholesterol, triglycerides, and total lipids only available for 173 samples.Environmental Health 2009, 8:32 http://www.ehjournal.net/content/8/1/32
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